Abstract: Mucosal-associated invariant T (MAIT) cells are an abundant antibacterial innate-like lymphocyte population. There are conflicting reports as to their fate in HIV infection. The objective of this study was to determine whether MAIT cells are truly depleted in HIV infection.
INTRODUCTION
M ucosal-associated invariant T (MAIT) cells are innatelike T cells that comprise $5% of the T-cell population in adult blood and are further enriched in mucosal and liver tissues. [1] [2] [3] MAIT cells are restricted by the nonpolymorphic, highly evolutionarily conserved major histocompatibility complex, class Ib-related protein (MR1). 2 MR1 has recently been shown to present a metabolite derived from the riboflavin synthetic pathway. 4, 5 Consistent with this, MAIT cells are activated by riboflavin-producing bacteria, including Mycobacterium tuberculosis, Escherichia coli, and Salmonella species. 6, 7 MAIT cells have also been shown to protect against bacterial infection in vivo, including against dissemination of bacillus Calmette-Guerin (BCG) in a mouse model. 8 MAIT cells have a semiinvariant T-cell receptor (TCR), Va7.2-Ja33, and utilize a limited range of Vb chains. 9 Additional minor MR1-restricted MAIT cell populations with Va7.2-Ja20 and Va7.2-Ja12 have recently been described through use of an MR1 tetramer. 10 MAIT cells are defined by high levels of expression of the C-type lectin, CD161. 3 More than 90% of MAIT cells are CD8aþ, whereas $7% are CD4/ CD8 double negative and <1% are CD4þ. 11 MAIT cells also express high levels of the interleukin (IL)-18 receptor and are able to make interferon-g in response to IL-12 and IL-18 in the absence of TCR stimulation. 12 Recently, several reports have identified a significant impact of HIV infection on MAIT cells. [13] [14] [15] [16] [17] [18] Although all studies show a loss of CD161þþ Va7.2þ MAIT cells, it has been suggested that MAIT cells downregulate CD161 after activation and that in HIV infection the frequency of MAIT cells (including both CD161þþVa7.2þ and CD161ÀVa7.2þ MAIT cells) is unchanged.
14 Importantly, the Va7.2 antibody (clone 3C10) used in all these studies [13] [14] [15] [16] [17] [18] is not specific for the canonical MAIT cell TCR, but in combination with CD161 expression accurately identifies MAIT cells. 3 Therefore, we sought to determine whether MAIT cells were preserved or depleted in HIV through quantitative real-time polymerase chain reaction (PCR) for the canonical MAIT cell TCR, Va7.2-Ja33.
METHODS

Blood Samples
Leukocyte cones from unidentified healthy controls (HCs) (n ¼ 38) were obtained from NHS Blood and Transplant. Blood was obtained from HIV-infected patients (HIVþ) in the Thames Valley (n ¼ 26) 19 and Swiss HIV cohorts (n ¼ 20) or HCs (n ¼ 12). Peripheral blood mononuclear cells (PBMCs) were purified on Lymphoprep gradients, 13 and cryopreserved prior to analysis. Clinical details of patients in the Thames Valley cohort are shown in Table 1 . Clinical details of the patients in the Swiss HIV cohort have previously been reported, 13 and are represented here in Table 1 .
Written, informed consent was given by participants. The collection of samples was approved by the relevant ethics committees (the Central University Research Ethics Committee at the University of Oxford and the relevant ethics committees at all the participating institutions in Switzerland).
Quantitative Real-Time Reverse Transcription-PCR
RNA was extracted from PBMCs (13 HCs, 15 HIVþ) using the MiniRNA extraction kit (Qiagen, Hilden, Germany) or, in sorting experiments, the NucleoSpin RNA isolation kit (Machery Nagel, Bethlehem, PA, USA), as per the manufacturer's instructions with on-column DNase digestion. Reverse transcription was performed with Superscript III using a mix of anchored oligo(dT)20 primers (0.625 mg) and random primers (2.25 mg) (all Life Technologies, Carlsbad, CA, USA) as per the manufacturer's instructions. Samples were then incubated with 2U of RNAseH (Life Technologies, Carlsbad, CA, USA) for 20 minutes at 37 o C before use in a real-time PCR. In sorting experiments, high-capacity RNA-to-cDNA kit (Life Technologies, Carlsbad, CA, USA) was used as per the manufacturer's instructions.
Genomic DNA Extraction
Genomic DNA (gDNA) was extracted from whole blood (12 HCs, 11 HIVþ) or PBMCs (10 HCs) as previously described. 20 The same volume of eluted DNA extracted from the same volume of blood was used for quantitative real-time PCR. In sorting experiments, the PureLink Genomic DNA Mini Kit (Life Technologies, Carlsbad, CA, USA) was used.
Quantitative Real-Time PCR 
Flow Cytometry
The following antibodies were used: Va7.2-PE, CD3-PECy7 (BioLegend, San Diego, CA, USA), CD4-VioGreen, CD161-APC (Miltenyi Biotec, Bergisch Gladbach, Germany), CD4-APCeFluor780, CD8-eFluor450 (eBiosciences, San Diego, CA, USA), CD3-Pacific Orange (Life Technologies, Carlsbad, CA, USA), CD8-PECy7 (BD Biosciences, San Jose, CA, USA). All samples were stained with Live/Dead Fixable Near IR dye (Life Technologies, Carlsbad, CA, USA). Samples were stained as previously described. 13 Flow cytometry was performed on a MACSQuant (Miltenyi Biotec, Bergisch Gladbach, Germany), an LSRII (BD Biosciences, San Jose, CA, USA), or for sorting experiments, on a FACSAria (BD Biosciences, San Jose, CA, USA). Samples were gated on lymphocytes/alive/CD3þ or lymphoctyes/alive/CD3þ/CD4À (Supplementary Figure 2 , http://links.lww.com/MD/A337). Analysis was performed in FlowJo 9.6 (Treestar, Inc., San Carlos, CA, USA). 
Statistical Analysis
No formal power calculation was performed. Data were analyzed in Prism 6 (GraphPad Software, San Diego, CA, USA). Medians and all data points are shown. Comparisons between groups were made by t tests with log 10 -normalized data. For comparison of C T values, nonnormalized data was used. For sorting experiments, a paired t test on log 10 normalized data was performed. Spearman correlations were calculated separately for HIVþ and HC cohorts. Significance was defined as 2-sided P 0.05.
RESULTS
The Va7.2 antibody not only recognizes MAIT cells, which express the canonical Va7.2-Ja33 TCR, but also other non-MAIT cell TCRs. Therefore, we sought to determine the number of MAIT cells in blood from HIV-infected and HIVuninfected donors by quantitative real-time reverse transcription (RT)-PCR. The expression of Va7.2-Ja33 relative to the Ca chain, which is expressed in all ab T cells, was determined. Va7.2-Ja33 messenger RNA (mRNA) was significantly less abundant in the blood of patients with HIV than uninfected controls (median relative expression of Va7.2-Ja33:Ca 0.00165 vs 0.00478, P ¼ 0.006) (Figure 1 ).
To confirm MAIT cell depletion at the cellular level, the same PBMCs were analyzed by flow cytometry. Frequencies were determined as a proportion of CD3þ lymphocytes (Figure 2A) . No difference in frequency of Va7.2þ T cells was seen ( Figure 2B ). Va7.2þCD161þþ cells were depleted (0.41% vs 1.93%, P ¼ 0.001) ( Figure 2C ) whereas Va7.2þCD161À cells were increased (2.52% vs 1.52%, P < 0.001) in HIV-infected patients compared with HCs ( Figure 2D ).
As depletion of CD4þ T cells in HIV distorts relative frequencies of other populations, and <1% of MAIT cells are CD4þ, 11 frequencies were also determined as a proportion of CD3þCD4À lymphocytes ( Figure 2E ). Va7.2þ cells were depleted in HIV-infected patients compared with HCs as a proportion of CD3þCD4À lymphocytes (4.27% vs 8.82%, P ¼ 0.021) ( Figure 2F ). In HIV-infected patients versus HC, Va7.2þCD161þþ cells were significantly depleted (0.60% vs 4.59%, P < 0.001) ( Figure 2G ), but no significant increase in Va7.2þCD161À cells was seen (3.69% vs 2.7%, P ¼ 0.053) ( Figure 2H ).
Next we determined which flow cytometric measure best correlated with the frequency of MAIT cells, as determined by quantitative RT-PCR. When CD4þ cells were included, there was no significant correlation between Va7.2-Ja33 mRNA levels and frequency of Va7.2þ T cells (r ¼ 0.19, P ¼ 0.49) in HIVinfected patients ( Figure 2I ). In contrast, Va7.2-Ja33 mRNA levels in HCs were significantly correlated with frequency of Va7.2þ T cells (r ¼ 0.85, P < 0.001) ( Figure 2I ). The frequency of Va7.2þCD161þþCD3þ cells significantly correlated with Va7.2-Ja33 mRNA levels in HIV-infected patients (r ¼ 0.90, P < 0.001) and HCs (r ¼ 0.81, P ¼ 0.001) ( Figure 2J ).
When CD4þ cells were excluded, the frequency of Va7.2þ cells among CD3þCD4-lymphocytes correlated significantly with Va7.2-Ja33 mRNA levels in HC (r ¼ Figure 2K ). Therefore, in HIV infection frequency of Va7.2þCD161þþ cells most accurately reflects abundance of MAIT cells.
To confirm that MAIT cells are depleted in HIV infection and that Va7.2þCD161À cells are not significantly enriched, we reanalyzed our previously published data from the Swiss HIV Cohort Study excluding CD4þ T cells. 13 Comparison of the pretreatment timepoint with HCs demonstrated a significant depletion of Va7.2þCD161þþ cells as a proportion of CD3þCD4À lymphocytes (1.10% vs 4.59% in HIVþ vs HC, P ¼ 0.002) ( Figure 3A ). No significant difference was seen in the proportion of Va7.2þCD161À cells (median 2.77% vs 2.65% in HIVþ vs HC, P ¼ 0.073) ( Figure 3B) .
As a selective downregulation of MAIT cell TCR expression could account for the apparent decrease in Va7.2-Ja33 mRNA abundance relative to Ca mRNA in HIV infection, we investigated whether MAIT cell gDNA was also depleted from blood. This is possible because during TCR rearrangement, the variable and junctional regions are joined together to form a single exon. 21 Using PBMCs from HC, we first confirmed that Va7.2-Ja33 gDNA abundance correlated with Va7.2-Ja33 mRNA abundance; as expected, a significant correlation was found (r ¼ 0.78, P ¼ 0.01) ( Figure 4A ). Furthermore, Va7.2-Ja33 gDNA abundance was strongly correlated with the frequency of Va7.2þCD161þþ cells among CD3þ lymphocytes (r ¼ 0.94, P < 0.001) ( Figure 4B ). Therefore, Va7.2-Ja33 gDNA abundance is a valid measure of absolute MAIT cell numbers. We measured the abundance of Va7.2-Ja33 gDNA in a different cohort of HIV-infected patients and compared it with HC. Consistent with the decreased relative abundance of Va7.2-Ja33 mRNA (Figure 1 ), there was a significant decrease in the relative abundance of Va7.2-Ja33 gDNA (median abundance of the Va7.2-Ja33 rearrangement relative to Ca 0.00344 vs 0.00061, P < 0.001) in HIVþ versus HCs ( Figure 4C ). As DNA was extracted from equal volumes of blood and equal volumes of extracted DNA were used as the template for PCR, C T could be used as a direct measure of MAIT cell abundance per volume of blood. The C T for Va7.2-Ja33 was significantly higher (median C T 30.93 vs 28.05, P < 0.001) in HIVþ versus HC ( Figure 4D ), confirming absolute depletion of the MAIT cell population.
To confirm the specificity of the PCR, RNA and DNA were extracted from FACS-sorted MAIT cells 
DISCUSSION
We have confirmed the loss of MAIT cells in blood in HIV by molecular and flow cytometric approaches. In HIV, decreased abundance of both Va7.2-Ja33 mRNA and gDNA was seen. Abundance of Va7.2-Ja33 mRNA correlated most strongly with the frequency of Va7.2þCD161þþ cells, irrespective of whether CD4þ T cells were included. Furthermore, no significant increase in frequency of Va7.2þCD161À cells was seen among CD3þCD4À lymphocytes.
A limitation of our study is that demographic data of HCs were not available. Therefore, age and sex cannot be excluded as confounding variables. It has recently been reported that the frequency of MAIT cells in blood is significantly lower in older (age 61-92 years) than younger (age 21-40 years) individuals. 22 However, given the low median age of the HIV-infected cohorts in our study (Table 1) , age is unlikely to explain the differences observed.
Loss of Va7.2þþCD161þþ MAIT cells in HIV infection has previously been reported. [13] [14] [15] [16] One potential mechanism for this is through downregulation of CD161, resulting in a change in phenotype rather than loss of TCRþ cells.
14 Indeed, in vitro MAIT cells downregulate CD161 upon activation. 14, 23 Given the disrupted intestinal epithelial integrity in HIV infection and the subsequent translocation of bacteria, 13, [24] [25] [26] activation of MAIT cells and subsequent downregulation of CD161 would be expected. However, our study suggests that the loss of Va7.2þCD161þþ MAIT cells in HIV infection cannot be solely explained by downregulation of CD161. In HIV-infected patients, the reduced abundance of Va7.2-Ja33 mRNA and gDNA, the unchanged frequency of Va7.2þCD161À cells among CD3þCD4À lymphocytes (despite the loss of Va7.2þCD161þþ cells, which would be expected to increase the relative frequency of this population), and the strong correlation of Va7.2-Ja33 mRNA levels with the frequency of Va7.2þCD161þþ cells but not total Va7.2þ cells, all argue that MAIT cells are lost from the blood in HIV infection.
Although our data does not exclude the presence of CD161À MAIT cells in blood in HIV infection, 2 recent studies, 1 in healthy donors and 1 in HIV-infected patients, found that MR1-tetramer-positive cells were not present in the CD161À compartment, 10, 17 confirming CD161 as a key marker. Furthermore, despite an increase in frequency of Va7.2þCD161ÀCD3þ cells as a percentage of CD3þ cells, no increase was seen in the number of Va7.2þCD161ÀCD3þ cells per microliter. 17, 18 This could be further investigated in future studies by quantifying the number of MAIT cell TCR transcripts in flow cytometry-sorted Va7.2þCD161À cells from the blood of HIV-infected patients.
Activation-induced cell death secondary to microbial translocation and/or sequestration in tissues are alternative explanations that have been suggested for the loss of MAIT cells from the blood in HIV infection. 13, 18 We have previously reported that in the colon, the absolute number of MDR1þþCD3þCD8þ T cells, a proxy for MAIT cells, was unchanged in HIV as assessed by immunohistochemistry. 13 Similarly, no depletion of Va7.2þCD161þþCD3þ cells was seen in rectal biopsies as measured by flow cytometry. 14 In contrast, it was recently reported that MAIT cells (defined as CD161þþCD8þCD3þ cells) were depleted as a proportion of CD8þCD3þ lymphocytes in the colon in HIV, with subsequent recovery after a median of 72 months of antiretroviral therapy. 27 Interestingly, blood MAIT cell frequencies fail to recover with antiretroviral therapy 13, 14 raising the possibility that recovery occurs first in the colon 27 and later in the blood. Recovery in blood should therefore be assessed over a longer follow-up period and perhaps also after interventions in very early infection. Furthermore, as the influx of CD8þ T cells into the colon in HIV infection may influence cell proportions, 13, [28] [29] [30] for measuring MAIT cell dynamics in the tissues during HIV infection and treatment. A limitation of our study is that our assay does not assess the abundance of Va7.2-Ja12 and Va7.2-Ja20 MAIT cells. Although Va7.2-Ja33 MAIT cells form the overwhelming majority of the blood MAIT cell population in most people, Va7.2-Ja12 and Va7.2-Ja20 MAIT cells can comprise up to 50% in some individuals. 10, 31 Va7.2-Ja12 MAIT cells also appear to be enriched in some tissues, although in most donors Va7.2-Ja33 MAIT cells still predominate. 31 Nonetheless, given that Va7.2-Ja12, Va7.2-Ja20, and Va7.2-Ja33 MAIT cell TCRs all bind to ligand-bound MR1, 10 there is no a priori reason to hypothesize that different subsets are differentially depleted in HIV infection compared with HCs. Therefore, although our analysis only involves a single Ja segment, it is the most abundant in the majority of individuals and the conclusions drawn could reasonably be expected to be applicable to MAIT cells containing alternative Ja segments (Ja12 and Ja20). The fate of alternative MAIT cell populations should be investigated in future studies.
The loss of MAIT cells in HIV may contribute to immunodeficiency. In vivo animal models suggest that MAIT cells have a nonredundant role in controlling systemic and mucosal infection with a range of bacteria, including BCG and Enterobacteriaceae. 7, 8, 32, 33 Given the increased rate of progression to active tuberculosis following infection with M tuberculosis 34 and the high rates of invasive nontyphoidal Salmonella infection in HIV infection, 35 it will be important to determine the role of MAIT cell depletion in HIV-induced immunodeficiency.
In conclusion, through the measurement of Va7.2-Ja33 mRNA and gDNA levels, we have confirmed that MAIT cells are depleted from the blood in HIV infection and that significant accumulation of a CD161À MAIT cell population is unlikely. Future studies to investigate the fate of MAIT cells in tissue in HIV infection, using these techniques, are warranted. 
